Comments
Loading...

Replimune Group Analyst Ratings

REPLNASDAQ
Logo brought to you by Benzinga Data
$9.88
At close: Jun 12 EDT
$9.55
-0.33-3.39%
Pre-Market: 7:59 PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$60.00
Lowest Price Target1
$17.00
Consensus Price Target1
$30.92

Replimune Group Analyst Ratings and Price Targets | NASDAQ:REPL | Benzinga

Replimune Group Inc has a consensus price target of $30.92 based on the ratings of 12 analysts. The high is $60 issued by EF Hutton on June 7, 2023. The low is $17 issued by Roth MKM on August 27, 2024. The 3 most-recent analyst ratings were released by Piper Sandler, JP Morgan, and HC Wainwright & Co. on June 2, 2025, February 26, 2025, and February 13, 2025, respectively. With an average price target of $20.67 between Piper Sandler, JP Morgan, and HC Wainwright & Co., there's an implied 116.40% upside for Replimune Group Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Jan
2
Feb
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
JP Morgan
HC Wainwright & Co.
BMO Capital
Jefferies

1calculated from analyst ratings

Analyst Ratings for Replimune Group

Buy NowGet Alert
06/02/2025Buy Now130.37%Piper Sandler
Allison Bratzel71%
$14 → $22MaintainsOverweightGet Alert
02/26/2025Buy Now88.48%JP Morgan
Anupam Rama60%
$16 → $18MaintainsOverweightGet Alert
02/13/2025Buy Now130.37%HC Wainwright & Co.
Robert Burns46%
$21 → $22MaintainsBuyGet Alert
01/22/2025Buy Now182.72%BMO Capital
Evan David Seigerman51%
$18 → $27MaintainsOutperformGet Alert
01/22/2025Buy Now119.9%HC Wainwright & Co.
Robert Burns46%
$17 → $21MaintainsBuyGet Alert
12/04/2024Buy Now98.95%Jefferies
Roger Song37%
$16 → $19MaintainsBuyGet Alert
11/22/2024Buy Now88.48%BMO Capital
Evan David Seigerman51%
$14 → $18MaintainsOutperformGet Alert
11/22/2024Buy Now78.01%HC Wainwright & Co.
Robert Burns46%
$17 → $17ReiteratesBuy → BuyGet Alert
11/12/2024Buy Now78.01%HC Wainwright & Co.
Robert Burns46%
$17 → $17ReiteratesBuy → BuyGet Alert
09/24/2024Buy Now78.01%JP Morgan
Anupam Rama60%
$14 → $17MaintainsOverweightGet Alert
09/16/2024Buy Now78.01%HC Wainwright & Co.
Robert Burns46%
$17 → $17ReiteratesBuy → BuyGet Alert
09/10/2024Buy Now78.01%HC Wainwright & Co.
Robert Burns46%
$17 → $17ReiteratesBuy → BuyGet Alert
08/27/2024Buy Now78.01%Roth MKM
Benjamin Paluch44%
→ $17Initiates → BuyGet Alert
08/13/2024Buy Now46.6%JP Morgan
Anupam Rama60%
$17 → $14MaintainsOverweightGet Alert
06/07/2024Buy Now78.01%Barclays
Peter Lawson43%
$13 → $17MaintainsOverweightGet Alert
06/07/2024Buy Now78.01%HC Wainwright & Co.
Robert Burns46%
$12 → $17MaintainsBuyGet Alert
12/06/2023Buy Now36.13%Barclays
Peter Lawson43%
$50 → $13MaintainsOverweightGet Alert
11/13/2023Buy Now402.62%HC Wainwright & Co.
Robert Burns46%
$50 → $48MaintainsBuyGet Alert
11/08/2023Buy Now444.5%Wedbush
Robert Driscoll45%
→ $52ReiteratesOutperform → OutperformGet Alert
08/07/2023Buy Now423.56%HC Wainwright & Co.
Robert Burns46%
$51 → $50MaintainsBuyGet Alert
08/01/2023Buy Now434.03%HC Wainwright & Co.
Robert Burns46%
→ $51ReiteratesBuy → BuyGet Alert
06/15/2023Buy Now423.56%JP Morgan
Anupam Rama60%
$38 → $50MaintainsOverweightGet Alert
06/08/2023Buy Now434.03%HC Wainwright & Co.
Robert Burns46%
→ $51ReiteratesBuy → BuyGet Alert
06/07/2023Buy Now444.5%Wedbush
Robert Driscoll45%
→ $52ReiteratesOutperform → OutperformGet Alert
06/07/2023Buy Now528.27%EF Hutton
Tony Butler42%
→ $60ReiteratesBuy → BuyGet Alert
06/05/2023Buy Now434.03%HC Wainwright & Co.
Robert Burns46%
$50 → $51MaintainsBuyGet Alert
06/05/2023Buy Now528.27%EF Hutton
Tony Butler42%
→ $60ReiteratesBuy → BuyGet Alert
05/26/2023Buy Now528.27%EF Hutton
Tony Butler42%
→ $60ReiteratesBuy → BuyGet Alert
05/22/2023Buy Now444.5%Wedbush
Robert Driscoll45%
→ $52ReiteratesOutperform → OutperformGet Alert
04/17/2023Buy Now360.73%Piper Sandler
Allison Bratzel71%
→ $44Assumes → OverweightGet Alert
02/10/2023Buy Now423.56%HC Wainwright & Co.
Robert Burns46%
$48 → $50Reiterates → BuyGet Alert
01/05/2023Buy Now528.27%EF Hutton
Tony Butler42%
→ $60Initiates → BuyGet Alert
12/12/2022Buy Now632.98%BMO Capital
Evan David Seigerman51%
$40 → $70MaintainsOutperformGet Alert
12/07/2022Buy Now256.02%SVB Leerink
Jonathan Chang38%
$30 → $34MaintainsOutperformGet Alert
11/04/2022Buy Now402.62%HC Wainwright & Co.
Robert Burns46%
$60 → $48MaintainsBuyGet Alert
10/14/2022Buy Now318.85%BMO Capital
Evan Seigerman62%
$30 → $40MaintainsOutperformGet Alert
10/03/2022Buy Now214.14%SVB Leerink
Jonathan Chang38%
$37 → $30MaintainsOutperformGet Alert
08/16/2022Buy Now350.26%Piper Sandler
Do Kim54%
$44 → $43MaintainsOverweightGet Alert
08/05/2022Buy Now287.43%SVB Leerink
Jonathan Chang38%
$48 → $37MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Replimune Group (REPL) stock?

A

The latest price target for Replimune Group (NASDAQ:REPL) was reported by Piper Sandler on June 2, 2025. The analyst firm set a price target for $22.00 expecting REPL to rise to within 12 months (a possible 130.37% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Replimune Group (REPL)?

A

The latest analyst rating for Replimune Group (NASDAQ:REPL) was provided by Piper Sandler, and Replimune Group maintained their overweight rating.

Q

When was the last upgrade for Replimune Group (REPL)?

A

There is no last upgrade for Replimune Group

Q

When was the last downgrade for Replimune Group (REPL)?

A

There is no last downgrade for Replimune Group.

Q

When is the next analyst rating going to be posted or updated for Replimune Group (REPL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on June 2, 2025 so you should expect the next rating to be made available sometime around June 2, 2026.

Q

Is the Analyst Rating Replimune Group (REPL) correct?

A

While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a maintained with a price target of $14.00 to $22.00. The current price Replimune Group (REPL) is trading at is $9.55, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch